Wet Cupping Therapy in Ankylosing Spondylitis

Last updated: February 21, 2026
Sponsor: Karabuk University
Overall Status: Completed

Phase

N/A

Condition

Arthritis And Arthritic Pain

Musculoskeletal Diseases

Ankylosing Spondylitis

Treatment

wet cupping therapy

Clinical Study ID

NCT05792358
SBU177
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study evaluates the efficacy of wet cupping therapy in patients with ankylosing spondylitis.Wet cupping therapy will be applied to half of the patients plus routine pharmaceutical treatment while the other half will receive only pharmaceutics

Eligibility Criteria

Inclusion

Inclusion Criteria:

Clinical diagnosis of ankylosing spondylitis 18-65 years of age Consent to participate

Exclusion

Exclusion Criteria:

Any ongoing medical treatment other than NSAIDs Pregnancy At least one contraindication to WCT that was detected in subject's history or in the routine blood examinations prior to enrollment (Hgb <9.5; INR> 1.2; history of hemophobia, bleeding disorder, malignant disorder).

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: wet cupping therapy
Phase:
Study Start date:
February 01, 2023
Estimated Completion Date:
October 30, 2025

Study Description

In addition to the medical treatment, WCT will be applied once a month, 3 times (Day 0, 30, 60) to the intervention group whereas the control group will not receive any intervention. The BASFI, BASDAI, VAS and Schober test will be applied to both groups at 0 and 3 months.

Connect with a study center

  • Karabuk University

    Karabuk,
    Turkey

    Site Not Available

  • Karabuk University

    Karabük 744562,
    Turkey (Türkiye)

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.